Company intelligence / Profile preview
Dermal Laboratories
- Ownership
- Private
- Development stage
- Commercial
Overview
Dermal Laboratories has over five decades of experience developing and commercializing novel dermatological treatments. Their products are trusted by healthcare professionals for the treatment of various skin disorders such as eczema, psoriasis, and ichthyosis. The company emphasizes both efficacy and cosmetic elegance in its topical formulations. No recent clinical trial results are publicly highlighted.
- Therapeutic areas
- Dermatology
- Modalities
- Topical formulationssmall molecules
- Industry
- Biotech
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Dermal Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermal Laboratories.